oversubscription

Stock market investors have shown a powerful response to Emcure Pharmaceuticals Limited’s initial public offering (IPO), with all three categories—Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Investors—displaying robust bidding figures on the third day of the offering. According to data from the Bombay Stock Exchange (BSE) website, the […]